SCHEMBL7652194

SCHEMBL7652194

CN1CCN(c2ccc(S(=O)(=O)Nc3ccc4oc(-c5ccc(O)c(O)c5)c(O)c(=O)c4c3)cc2N)CC1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CDK2 P24941 9/20 0.53
MEN1 O00255 4/20 0.42
KMT2A Q03164 4/20 0.42
MAPT P10636 3/20 0.41
MAPK1 P28482 3/20 0.41
KDM4E B2RXH2 2/20 0.41
TP53 P04637 2/20 0.41
CYP3A4 P08684 2/20 0.41
CYP2C9 P11712 2/20 0.41
ALOX15 P16050 2/20 0.41
ALOX12 P18054 2/20 0.41
RECQL P46063 2/20 0.41
HSD17B10 Q99714 2/20 0.41
CYP2D6 P10635 1/20 0.41
ST6GAL1 P15907 1/20 0.41
CYP2C19 P33261 1/20 0.41
SMN1; SMN2 Q16637 2/20 0.41
BCL9 O00512 2/20 0.40
CTNNB1 P35222 2/20 0.40
LMNA P02545 2/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7658645 0.89 LMNA (0.54) CDK2MEN1KMT2AMAPTMAPK1
SCHEMBL7651986 0.80 MEN1 (0.51) CDK2MEN1KMT2AMAPTMAPK1
SCHEMBL7660305 0.79 MEN1 (0.53) CDK2MEN1KMT2AMAPTMAPK1
SCHEMBL7658419 0.79 LMNA (0.51) MEN1KMT2AMAPTMAPK1KDM4E
SCHEMBL7658366 0.78 MEN1 (0.50) CDK2MEN1KMT2AMAPTMAPK1
SCHEMBL7661882 0.77 MEN1 (0.52) CDK2MEN1KMT2AMAPTMAPK1
SCHEMBL7660698 0.77 MAPT (0.58) CDK2MEN1KMT2AMAPTMAPK1
SCHEMBL7663357 0.77 KDM4E (0.52) CDK2MEN1KMT2AMAPTMAPK1
SCHEMBL7654780 0.77 KMT2A (0.55) CDK2MEN1KMT2AMAPTMAPK1
SCHEMBL7659889 0.76 TDP1 (0.53) CDK2MEN1KMT2AMAPTMAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6500846-B1 2-(4-CHLOROPHENYL)-7-METHOXYCHROMEN-4-ONE, AS CYCLIN-DEPENDENT KINASE INHIBITORS, USED AS ANTICARCINOGENIC AGENTS OR FOR PROPHYLAXIS OF NEURODEGENERATIVE DISEASE LG CHEMICAL, LTD. (KR) 2002-12-31 US claimed
EP-1109800-A1 NOVEL CDK INHIBITORS HAVING FLAVONE STRUCTURE LG CHEMICAL LIMITED (KR) 2001-06-27 EP claimed
WO-2000012496-A1 NOVEL CDK INHIBITORS HAVING FLAVONE STRUCTURE LG CHEMICAL LTD. (KR) 2000-03-09 WO claimed
US-6500846-B1 2-(4-CHLOROPHENYL)-7-METHOXYCHROMEN-4-ONE, AS CYCLIN-DEPENDENT KINASE INHIBITORS, USED AS ANTICARCINOGENIC AGENTS OR FOR PROPHYLAXIS OF NEURODEGENERATIVE DISEASE LG CHEMICAL, LTD. (KR) 2002-12-31 US disclosed
EP-1109800-A1 NOVEL CDK INHIBITORS HAVING FLAVONE STRUCTURE LG CHEMICAL LIMITED (KR) 2001-06-27 EP disclosed
WO-2000012496-A1 NOVEL CDK INHIBITORS HAVING FLAVONE STRUCTURE LG CHEMICAL LTD. (KR) 2000-03-09 WO disclosed